Update on Biomarkers in Spinal Muscular Atrophy

The availability of disease modifying therapies for spinal muscular atrophy (SMA) has created an urgent need to identify clinically meaningful biomarkers. Biomarkers present a means to measure and evaluate neurological disease across time. Changes in biomarkers provide insight into disease progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pino, Megan G, Rich, Kelly A, Kolb, Stephen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371741/
https://www.ncbi.nlm.nih.gov/pubmed/34421296
http://dx.doi.org/10.1177/11772719211035643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371741/
https://www.ncbi.nlm.nih.gov/pubmed/34421296
http://dx.doi.org/10.1177/11772719211035643

Ejemplares similares